SSH Archives - Blue Horseshoe Stocks

Blue Horseshoe Stocks: FNBC Review & More

First NBC Bank Holding Co. FNBC

As we were just mentioning yesterday morning, we first alerted on FNBC in Monday’s premarket report after noticing that the stock was looking oversold and searching for a bottom.

It did indeed find that bottom at .0932 on Tuesday, from which point it has launched a multi-day recovery, setting an amazing new high of .89 yesterday. From its morning low of .29 it ran 207% intraday, and from our observed low, a whopping 855% move up in a span of three trading sessions! It’s also worth it to mention that there is still a gap to fill on the chart up to the 2.50-range.

This definitely goes down in the books as our most exciting call to watch this week, and cheers go out to any of our readers who caught on and made a pretty penny!

Ampliphi BioSciences Corp. APHB

APHB was among our tracked stocks from yesterday morning’s report, and it yielded a very nice intraday chance with its daily performance. The stock traded up from a morning low of 2.17 and hit 4.88 just prior to lunch hour on massive volume to the tune of more than 87 times the 30-day average!

That worked out to a great move of 125% on the day, so despite gapping down in early trading this morning, we’re pleased with the opportunity APHB offered during yesterday’s session. Additionally, with the extreme volume and volatility in this stock, we won’t rule out seeing another pop from APHB on the eventual rebound.

Northern Dynasty Minerals, Ltd. NAK

We also want to give an update on NAK, which we last tagged at the end of March. Early April brought a considerable upswing from 1.21-1.85, a 53% move. Over the past several sessions that followed the stock has been under consolidation, and we want to come back around to put it on our radars again, as it looks as if it may be getting ready for its next leg up.

The RSI and MACD, which are typically some of our favorite technical indicators aren’t giving off strong signals either way at the moment, but the stock recorded a hammer candle yesterday. In a downtrend, that can be a bullish reversal signal, so we want to keep an eye on NAK as we close out the trading week.

SPDR S&P 500 ETF (SPY) – Options Idea

We also wanted to make it known that we are going to be tracking some SPY Calls today to coincide with a promising jobs numbers release, and what seems like it could be a bullish day for the markets as a whole. We’ll have the SPY Weekly $238-50-239.50 Calls* on our watchscreens today.

*Never attempt to trade weekly options on a Friday unless you are a highly experienced trader- it’s an exceedingly risky proposition.

Extended Watchlist:
COTE, GOGL, SSH, BPMX, CTRV,

Blue Horseshoe Stocks: Bottom-Bouncers & More

North Atlantic Drilling Ltd. NADL

We’ve got an array of potential bottom-bounce plays to go over this morning, the first of which is NADL. This stock has been getting beaten down incrementally since reaching a high of 4.80 in December. It’s been one selloff after another since then, culminating in a low of .65 during yesterday’s session.

We’re seeing a moderate gap-up this morning, and want to put NADL on our watchlist moving forward on the chance that a multi-day rebound is on the way.

__________

Catalyst BioSciences, Inc. CBIO

Next up on our bottom-bounce watchlist is CBIO, which is also gapping up off of a bottom in the premarket this morning with the help of a key press release, of which we’ll include a snippet below.

The stock recently made a massive run to the $18, so the potential for another major move is certainly present.

SOUTH SAN FRANCISCO, Calif., April 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc., (Nasdaq:CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a key milestone under its collaboration with ISU Abxis to advance the Factor IX program towards its first human clinical trial. Completion of the CB 2679d/ISU304 toxicology studies supported the recent Investigational New Drug (IND) approval by the Korean Ministry of Food and Drug Safety (MFDS) and triggered a milestone payment to Catalyst. (>>View Full PR)
__________

Sunshine Heart, Inc. SSH

We tagged SSH as a bottom play a week ago today on the 4th, and subsequently tracked it over a pretty nice run last week as it traded up from 1.67 and hit 2.25 (+35%). It pulled back to the low 1.70’s yesterday and appears to be gearing up for another possible move.

Just two months ago the stock was trading at more than $5/share, so we wanted to add a little reminder this morning that SSH could be line for an extended recovery that we’ll want to look out for in the day and weeks ahead.

Galectin Therapeutics, Inc. GALT

We were just mentioning yesterday morning the excellent move from GALT we had witnessed between first bringing it up in January and the present. The run, originating at a low of .935 had already reached just beyond the 200% level, and after a very nice intraday performance, our observed range was extended even further.

Trading up from a morning low to 2.75, the stock traded up 34% to reach 3.68. That pushed the overall percentage gain we’ve witnessed in GALT for 2017 to a highly respectable 294%

Extended Watchlist:
AMLH, SALE, GLBS, AKER, STAF

Blue Horseshoe Stocks: MMEX Keeps Rolling & More

MMEX Resources Corp. MMEX

We’re looping back for yet another update on MMEX, which we’ve been mentioning quite a bit after our March 22nd alert gave us the chance to get in at a low of .0046; the stock has since gone on an exponential tear that hasn’t slowed down a bit over the past few sessions.

By our update on Friday morning, the stock had made it to just below .017, and that’s when things really took off, with the past couple of sessions providing the most intense spikes yet.

Yesterday that culminated in a new high with a solid 96% daily run from .028-.055. That brings our total observed range on MMEX in just nine trading days, to 1096%

Cyclacel Pharmaceuticals, Inc. CYCC

We highlighted CYCC as a potential bottom-play in Friday morning’s premarket report, pointing out that it was giving off a strong double-bottom signal along with having previously demonstrated potential for volatility. We turned out to be spot on with our calling the stock a prime bottom-play, as it has produced a very impressive two-day upswing since then, with the help of the release of some intriguing study data (>>View News).

Our observed range on CYCC since Friday morning is from 3.39 to 6.59, representing a 94% move, while volume yesterday absolutely exploded to the tune of more than 112X its 30-day average volume! It also closed near the high of day so we’re definitely going to want to continue tracking it as the week progresses. Dip-and-rip scenarios could certainly come into play in such a situation.
______

Added Notes:

While we’re on the subject of bottom-plays, we want to add a couple more to our radar this morning with Atossa Genetics, Inc. ATOS and Argos Therapeutics, Inc. ARGS. ATOS still appears to be searching for its bottom, so we’ll be watching for that, while ARGS has already begun to get a leg up. We’ll look for a continuation of the establishing trend on that one.

Special Reminder:

We have a new pick coming out tomorrow morning that we’re excited to share with our readers. It operates in the rapidly burgeoning mobile payment processing sector, which is an exciting and forward-thinking space. Be sure to scan your inbox tomorrow between 9AM and the open so you don’t miss out!

Extended Watchlist:
AMLH, AFSI, EVOK, SSH, PTN, IGC

Blue Horseshoe Stocks: Mid-Week Review

U.S. Stem Cell, Inc. USRM

Today marks the fourth consecutive morning that we’ve addressed USRM in our premarket report, granted the fact that it has gone on a multi-day run setting new highs one after the other.

During yesterday’s session, USRM traded in a range from .096 to .1793, a fantastic intraday swing of 87% From the low of .014 we caught immediately following our report on February 27th, the total increase we observed in just a shade over a month amounts to an incredible 1180%

The stock closed at .125, but the volume cooled down to just slightly more than the 30-day average. We’ll remain interested in tracking USRM as long as it can continue to build higher base levels of support.

Sunshine Heart, Inc. SSH

We tagged SSH in yesterday morning’s extended watchlist, after identifying it as a possible bottom-bouncer, and ended up providing a pretty good opportunity for a quick intraday gain which could be just the start.

The stock traded in a range from 1.67 to 2.38 for a 43% pop, and perhaps more importantly, closed with strength at 2.31 having traded more than four times the monthly average volume on the day.

That performance will have us on the lookout for a possible continuation of momentum and give SSH a chance to formulate a multi-day run.

Dollar Tree, Inc. DLTR – Options Update

We also want to give a quick update on the performances of a set of DLTR options we alerted a week ago today. The DLTR 04/21 $78-80 Calls have provided the following gain opportunities since then:

$78 Calls – .51-1.18 (+131%)
$79 Calls – .48-.90 (+88%)
$80 Calls – .30-.61 (+103%)

The $78.50’s and the $79.50’s, also included in our highlighted range, also made commensurate gains to what’s listed above.

Extended Watchlist:
POTN, VRTX, CBIO, TNXP, RH

Blue Horseshoe Stocks: Week Kicks Off on High Note

Yesterday, despite the fact that the markets as a whole were on pace for the longest sustained backslide in more than half a decade, we still managed to see new highs in a few of the stocks we’ve been tracking. We also observed solid intraday performances from a couple other plays that were on our morning watchlist, so we’ll begin today with a quick roundup of all these movers.

Dolat Ventures, Inc. DOLV

We signaled our interest in tracking DOLV in Thursday’s report, and at the time we’d witness the stock trading at a low of .0056.

Yesterday concluded with a new high, and the recording of three straight bullish sessions since then, with DOLV trading in an intraday range from .0125 to .019, for a gain of 52% It brings the updated figure on the three session swing we’ve seen so far to an impressive 239%

MyDx, Inc. MYDX

We circled back to MYDX, a stock we’ve tracked all the way from a February low of .001, last Wednesday, while it was trading as low as .0077. It too has put together a multi-day run leading to impressive new highs once again yesterday.

The stock saw a daily range of .017-.0226, which represents an increase of 32% on the day, 193% from last Wednesday’s low, and a ridiculous 2160% from our witnessed low in February!

U.S. Stem Cell, Inc. USRM

Here’s another stock whose low (.014) came during the month of February, following our report on the 27th. We’ve been all over it since then , and in two sustained bursts it has absolutely soared.

After reminding our readers of that fact in yesterday’s premarket report, USRM managed to hit yet another new high for us. It traded from .07-.112 for a daily boost of 60% and the new high recorded pushed our overall observed gain on this play in just one months time to an even 700%

Honorable Mentions

We placed a couple of plays in yesterday’s extended watchlist that didn’t blow our minds by any stretch of the imagination, but did log some solid intraday increases that warrant continued observation for each of them.

Catalyst Pharmaceuticals, Inc. CPRX
Daily Range: 1.63-2.07 – Max Gain: 27%

Impax Laboratories, Inc. IPXL
Daily Range: 10.50-13.00 – Max Gain: 24%

Extended Watchlist:
BRSE, OWCP, CARA, NVIV, SHIP, SSH, SBLK